Vlad Coric's most recent trade in Royalty Pharma plc - Ordinary Shares - Class A was a trade of 7,614 Class A Ordinary Shares done . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Pharma plc - Ordin... | Vlad Coric | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 7,614 | 10,798 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Vlad Coric | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2025 | 3,184 | 3,184 | - | 0 | Class A Ordinary Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2025 | 343,000 | 343,000 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2025 | 57,000 | 57,000 | - | - | Restricted Share Unit Award | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2025 | 14,250 | 42,750 | - | - | Restricted Share Unit Award | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2025 | 14,250 | 1,803,409 | - | 0 | Common Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.64 per share. | 05 Jan 2025 | 6,805 | 1,796,604 | - | 38.6 | 262,945 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 47.50 per share. | 02 Oct 2024 | 21,052 | 861,942 | - | 47.5 | 999,970 | Common Shares |
| Revance Therapeutics Inc | Vlad Coric | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 23,458 | 23,458 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Vlad Coric | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 15,000 | 20,784 (0%) | 0% | 0 | Common Stock | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 41.00 per share. | 22 Apr 2024 | 121,951 | 1,788,417 | - | 41 | 4,999,991 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 232 | 1,666,466 | - | - | Common Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 231 | 407,213 | - | - | Common Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 231 | 840,890 | - | - | Common Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 2,162 | 1,666,234 | - | - | Common Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 2,155 | 840,659 | - | - | Common Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 2,155 | 406,982 | - | - | Common Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 5,400 | 1,662,431 | - | - | Common Shares | |
| Biohaven Ltd | Coric Vlad | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 5,384 | 404,827 | - | - | Common Shares | |
| Biohaven Ltd | Coric Vlad | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 5,384 | 838,504 | - | - | Common Shares | |
| Biohaven Ltd | Coric Vlad | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 275,000 | 275,000 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2023 | 225,000 | 225,000 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 22.00 per share. | 05 Oct 2023 | 340,908 | 833,120 | - | 22 | 7,499,976 | Common Share |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 22.00 per share. | 05 Oct 2023 | 113,637 | 1,657,031 | - | 22 | 2,500,014 | Common Shares |
| Revance Therapeutics Inc | Vlad Coric | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 986 | 986 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Vlad Coric | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 589 | 5,784 (0%) | 0% | 0 | Common Stock | |
| Revance Therapeutics Inc | Vlad Coric | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,576 | 8,576 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Vlad Coric | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 5,195 | 5,195 (0%) | 0% | 0 | Common Stock | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 15.97 per share. | 31 Oct 2022 | 25,800 | 1,543,394 | - | 16.0 | 411,995 | Common Stock |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 14.82 per share. | 28 Oct 2022 | 100,000 | 109,565 | - | 14.8 | 1,482,420 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 14.87 per share. | 28 Oct 2022 | 41,930 | 1,517,594 | - | 14.9 | 623,352 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.50 per share. | 25 Oct 2022 | 853,380 | 1,475,664 | - | 10.5 | 8,960,490 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.83 per share. | 05 Oct 2022 | 80,907 | 437,883 | - | 10.8 | 875,843 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.82 per share. | 05 Oct 2022 | 80,606 | 344,820 | - | 10.8 | 871,907 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 8.82 per share. | 05 Oct 2022 | 73,331 | 322,461 | - | 8.8 | 647,029 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 8.82 per share. | 05 Oct 2022 | 73,005 | 229,755 | - | 8.8 | 644,130 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 11.83 per share. | 05 Oct 2022 | 54,329 | 492,212 | - | 11.8 | 642,614 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 11.79 per share. | 05 Oct 2022 | 52,523 | 397,343 | - | 11.8 | 619,162 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 9.90 per share. | 05 Oct 2022 | 34,515 | 356,976 | - | 9.9 | 341,843 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 9.89 per share. | 05 Oct 2022 | 34,459 | 264,214 | - | 9.9 | 340,968 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 12.35 per share. | 05 Oct 2022 | 2,100 | 399,443 | - | 12.3 | 25,928 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 249,130 | 249,130 | - | 0 | Common Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 156,750 | 156,750 | - | 0 | Common Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 46,025 | 622,284 | - | 0 | Common Shares | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 9,565 | 9,565 | - | 0 | Common Shares |